[ET Net News Agency, 27 January 2025] HANSOH PHARMA (03692) rose 3.1% to HK$17.96,
breaking above the 50-D SMA of HK$17.736.
It hits an intra-day high of HK$17.96, and an intra-day low of HK$17.34. The total
shares traded was 2.17 million, with a value of HK$38.59m. The active buy/sell ratio is
56:44, with net buying turnover of HK$4.29m. GOLDMAN SACHS (ASIA) SEC accounts for
greatest net responsive buying turnover of HK$4.13m, with volume weighted average price of
HK$17.771. MORGAN STANLEY HK SEC accounts for greatest net responsive selling turnover of
HK$4.15m, with volume weighted average price of HK$17.856. The stock has risen a combined
3.9% over the past 2 consecutive trading days.
The Hang Seng Index now rose 195 points, or 1% to 20,261.
Basic Information
=================
---------------------------------
Nominal 17.960 % Chg +3.10%
High 17.960 Low 17.340
Shares Tr 2.17m Turnover 38.59m
10-D SMA 17.116 %H.V 23.028
20-D SMA 16.864 VWAP 17.795
50-D SMA 17.736 RSI14 61.300
---------------------------------
Status: Breaking above the 50-D SMA, active buy/sell ratio is 56:44, with net buying
turnover of HK$4.29m, rising a combined 3.9% over the past 2 consecutive trading days
Performance of stocks in the same sector or of relevance
========================================================
Stock (Code) Price (HK$) Change (%)
-----------------------------------------------
HANSOH PHARMA (03692) 17.96 +3.10
CSPC PHARMA (01093) 4.52 +2.26
SINOPHARM (01099) 20.45 +1.74
SINO BIOPHARM (01177) 2.92 +1.74
INNOVENT BIO (01801) 33.20 +2.63
WUXI BIO (02269) 18.64 +2.19
WUXI APPTEC (02359) 56.30 +0.81
CHINARES PHARMA (03320) 5.23 +1.16
BEIGENE (06160) 134.30 +2.44
AKESO (09926) 60.50 -3.35
-----------------------------------------------
(ed)